The conserved sumoylation consensus site in TRIM5α modulates its immune activation functions

Virus Research

Volumn 184, Issue , 2014, Pages 30-38

  Nepveu Traversy, Marie Édith ^a   Berthoux, Lionel ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

AP 1; NF B; Restriction; Sumoylation; TRIM5 ; Ubiquitylation

Indexed keywords

ARGININE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; SUMO PROTEIN; TRANSCRIPTION FACTOR AP 1; TRIPARTITE MOTIF PROTEIN 5; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; MUTANT PROTEIN; PROTEIN; TRIM5(ALPHA) PROTEIN, RHESUS MONKEY;

ARTICLE; CELL STRAIN HEK293; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; INNATE IMMUNITY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RING FINGER MOTIF; SUMOYLATION; UBIQUITINATION; WESTERN BLOTTING; AMINO ACID SUBSTITUTION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; RETROVIRUS; RHESUS MONKEY; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; ANIMALS; ARGININE; LYSINE; MACACA MULATTA; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; NF-KAPPA B; PROTEINS; RETROVIRIDAE; SUMOYLATION; TRANSCRIPTION FACTOR AP-1;

EID: 84898606389     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2014.02.013     Document Type: Article

References (54)

1. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J. Virol. 1997, 71(8):5871-5877.
2. Arriagada G., Muntean L.N., Goff S.P. SUMO-interacting motifs of human TRIM5alpha are important for antiviral activity. PLoS Pathog. 2011, 7(4):e1002019.
3. Berthoux L., Sebastian S., Sokolskaja E., Luban J. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J. Virol. 2004, 78(21):11739-11750.
4. 3 enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 2003, 77(5):3167-3180.
5. Bérubé J., Bouchard A., Berthoux L. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells. Retrovirology 2007, 4:68.
6. Black L.R., Aiken C. TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J. Virol. 2010, 84(13):6564-6569.
7. Brandariz-Nunez A., Roa A., Valle-Casuso J.C., Biris N., Ivanov D., Diaz-Griffero F. Contribution of SUMO-interacting motifs and SUMOylation to the antiretroviral properties of TRIM5alpha. Virology 2013, 435(2):463-471.
8. Campbell E.M., Dodding M.P., Yap M.W., Wu X., Gallois-Montbrun S., Malim M.H., Stoye J.P., Hope T.J. TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol. Biol. Cell 2007, 18(6):2102-2111.
9. Christensen D.E., Brzovic P.S., Klevit R.E. E2-BRCA1 RING interactions dictate synthesis of mono- or specific polyubiquitin chain linkages. Nat. Struct. Mol. Biol. 2007, 14(10):941-948.
10. Diaz-Griffero F., Gallo D.E., Hope T.J., Sodroski J. Trafficking of some old world primate TRIM5alpha proteins through the nucleus. Retrovirology 2011, 8:38.
11. Diaz-Griffero F., Li X., Javanbakht H., Song B., Welikala S., Stremlau M., Sodroski J. Rapid turnover and polyubiquitylation of the retroviral restriction factor TRIM5. Virology 2006, 349(2):300-315.
12. Fryrear K.A., Guo X., Kerscher O., Semmes O.J. The Sumo-targeted ubiquitin ligase RNF4 regulates the localization and function of the HTLV-1 oncoprotein Tax. Blood 2012, 119(5):1173-1181.
13. Geoffroy M.C., Chelbi-Alix M.K. Role of promyelocytic leukemia protein in host antiviral defense. J. Interferon Cytokine Res. 2011, 31(1):145-158.
14. Gocke C.B., Yu H., Kang J. Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 2005, 280(6):5004-5012.
15. Hess J., Angel P., Schorpp-Kistner M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 2004, 117(Pt 25):73-5965.
16. Journo C., Bonnet A., Favre-Bonvin A., Turpin J., Vinera J., Cote E., Chevalier S.A., Kfoury Y., Bazarbachi A., Pique C., Mahieux R. Human T cell leukemia virus type 2 tax-mediated NF-kappaB activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J. Virol. 2013, 87(2):1123-1136.
17. Keckesova Z., Ylinen L.M., Towers G.J. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(29):10780-10785.
18. Kim H.T., Kim K.P., Lledias F., Kisselev A.F., Scaglione K.M., Skowyra D., Gygi S.P., Goldberg A.L. Certain pairs of ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s) synthesize nondegradable forked ubiquitin chains containing all possible isopeptide linkages. J. Biol. Chem. 2007, 282(24):17375-17386.
19. Kutluay S.B., Perez-Caballero D., Bieniasz P.D. Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog. 2013, 9(3):e1003214.
20. Langelier C.R., Sandrin V., Eckert D.M., Christensen D.E., Chandrasekaran V., Alam S.L., Aiken C., Olsen J.C., Kar A.K., Sodroski J.G., Sundquist W.I. Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication. J. Virol. 2008, 82(23):11682-11694.
21. Li X., Kim J., Song B., Finzi A., Pacheco B., Sodroski J. Virus-specific effects of TRIM5alpha(rh) RING domain functions on restriction of retroviruses. J. Virol. 2013, 87(13):7234-7245.
22. Lienlaf M., Hayashi F., Di Nunzio F., Tochio N., Kigawa T., Yokoyama S., Diaz-Griffero F. Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha. J. Virol. 2011, 85(17):8725-8737.
23. Lim K.L., Chew K.C., Tan J.M., Wang C., Chung K.K., Zhang Y., Tanaka Y., Smith W., Engelender S., Ross C.A., Dawson V.L., Dawson T.M. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 2005, 25(8):9-2002.
24. Lukic Z., Goff S.P., Campbell E.M., Arriagada G. Role of SUMO-1 and SUMO interacting motifs in rhesus TRIM5alpha-mediated restriction. Retrovirology 2013, 10:10.
25. Lukic Z., Hausmann S., Sebastian S., Rucci J., Sastri J., Robia S.L., Luban J., Campbell E.M. TRIM5alpha associates with proteasomal subunits in cells while in complex with HIV-1 virions. Retrovirology 2011, 8:93.
26. Maegawa H., Miyamoto T., Sakuragi J., Shioda T., Nakayama E.E. Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology 2010, 399(2):212-220.
27. Muller S., Matunis M.J., Dejean A. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 1998, 17(1):61-70.
28. Naviaux R.K., Costanzi E., Haas M., Verma I.M. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 1996, 70(8):5701-5705.
29. Perron M.J., Stremlau M., Lee M., Javanbakht H., Song B., Sodroski J. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J. Virol. 2007, 81(5):2138-2148.
30. Perron M.J., Stremlau M., Song B., Ulm W., Mulligan R.C., Sodroski J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(32):11827-11832.
31. Pertel T., Hausmann S., Morger D., Zuger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., Bisiaux A., Albert M.L., Strambio-De-Castillia C., Mothes W., Pizzato M., Grutter M.G., Luban J. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472(7343):361-365.
32. Pham Q.T., Bouchard A., Grutter M.G., Berthoux L. Generation of human TRIM5alpha mutants with high HIV-1 restriction activity. Gene Ther. 2010, 17(7):859-871.
33. Poulsen S.L., Hansen R.K., Wagner S.A., van Cuijk L., van Belle G.J., Streicher W., Wikstrom M., Choudhary C., Houtsmuller A.B., Marteijn J.A., Bekker-Jensen S., Mailand N. RNF111/Arkadia is a SUMO-targeted ubiquitin ligase that facilitates the DNA damage response. J. Cell Biol. 2013, 201(6):797-807.
34. Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L., Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S., Pelicci P.G., Ballabio A. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20(9):2140-2151.
35. Rold C.J., Aiken C. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog 2008, 4(5):e1000074.
36. Sampson D.A., Wang M., Matunis M.J. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J. Biol. Chem. 2001, 276(24):21664-21669.
37. Sayah D.M., Sokolskaja E., Berthoux L., Luban J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430(6999):569-573.
38. Sebastian S., Luban J. TRIM5alpha selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005, 2:40.
39. Sebastian S., Sokolskaja E., Luban J. Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner. J. Virol. 2006, 80(4):2051-2054.
40. Song B., Gold B., O'Huigin C., Javanbakht H., Li X., Stremlau M., Winkler C., Dean M., Sodroski J. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J. Virol. 2005, 79(10):6111-6121.
41. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427(6977):848-853.
42. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D.J., Sundquist W.I., Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(14):5514-5519.
43. Tareen S.U., Emerman M. Human Trim5alpha has additional activities that are uncoupled from retroviral capsid recognition. Virology 2011, 409(1):113-120.
44. Tareen S.U., Emerman M. Trim5 TAKes on pattern recognition. Cell Host Microbe 2011, 9(5):349-350.
45. Towers G.J. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40.
46. Uchil P.D., Hinz A., Siegel S., Coenen-Stass A., Pertel T., Luban J., Mothes W. TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 2013, 87(1):257-272.
47. Vertegaal A.C. Small ubiquitin-related modifiers in chains. Biochem. Soc. Trans. 2007, 35(Pt 6):1422-1423.
48. Xu M., Skaug B., Zeng W., Chen Z.J. A ubiquitin replacement strategy in human cells reveals distinct mechanisms of IKK activation by TNFalpha and IL-1beta. Mol. Cell 2009, 36(2):302-314.
49. Yamauchi K., Wada K., Tanji K., Tanaka M., Kamitani T. Ubiquitination of E3 ubiquitin ligase TRIM5 alpha and its potential role. FEBS J. 2008, 275(7):1540-1555.
50. Yap M.W., Nisole S., Lynch C., Stoye J.P. Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(29):10786-10791.
51. Zane L., Jeang K.T. The importance of ubiquitination and sumoylation on the transforming activity of HTLV Tax-1 and Tax-2. Retrovirology 2012, 9:103.
52. Zhao J. Sumoylation regulates diverse biological processes. Cell. Mol. Life Sci. 2007, 64(23):3017-3033.
53. Zhong B., Tien P., Shu H.B. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology 2006, 352(1):14-21.
54. Zufferey R., Nagy D., Mandel R.J., Naldini L., Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15(9):871-875.